Mosaic ImmunoEngineering, Inc. (CPMV)

Market Cap	5.10M +17.3%
Revenue (ttm)	n/a
Net Income	-671.75K
EPS	-0.10
Shares Out	7.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	792
Open	0.4010
Previous Close	0.3570
Day's Range	0.4010 - 0.4010
52-Week Range	0.2520 - 1.0500
Beta	-0.74
RSI	56.18
Earnings Date	Feb 27, 2026

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2020
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: CPMV